Ocwen Financial Corp. (NYSE:OCN) estimates have been increased by Bank of America Merrill Lynch as a means to reflect a possible tax rate change. Shares have a Buy rating.
Emeritus Corp. (NYSE:ESC) target has been raised by Stifel Nicolaus due to the firm’s expectations that the company will see benefits from ongoing favorable industry fundamentals along with strong valuations in regards to senior housing real estate. The firm believes that senior housing operations are solid in Q3, and it reiterates its Buy rating on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Threshold Pharmaceuticals Inc. (NASDAQ:THLD) target has been raised by Stifel Nicolaus since the firm views the company’s three month survival data of its high dose TH-302 treatment as compelling. The firm continues to be confident that TH-302 has the potential to achieve the primary endpoint in the upcoming Phase III pancreatic cancer trial, and it keeps its Buy rating on the stock.
Citigroup, Inc. (NYSE:C) rallied 30 percent from its July lows, causing Sterne Agee to think that the bank could be harmed by currency fluctuations, as uncertainty about regulation continues as prospects for reserve release in Holdings decrease. Them firm reiterates its Neutral rating on the stock.
Sequenom Inc. (NASDAQ:SQNM) has not lost customers to competitors like Ariosa or Verinata management stated in a conference call with Maxim. Maxim believes that Sequenom is still progressing with payors, and it believes that the company will add more regional contracts during Q3. Maxim recommends buying the stock following its call, and it maintains its Buy rating and a $6 price target on the stock.